Robert Baltera Jr. - 08 Jul 2026 Form 4 Insider Report for PALISADE BIO, INC. (PALI)

Reporting relationship: Director
Issuer ticker: PALI
Reported as of: 08 Jul 2026
Net transaction value: +$88,698
SEC form: 4
Accepted by SEC: 10 Jul 2026, 18:14:21 UTC
Prior SEC filing: 08 Jul 2026
Source filing: View source filing
Reporting owner signature: /s/ Ryker Willie, Attorney-in-Fact for Robert Baltera Jr.

Key filing fact

Robert Baltera Jr. filed Form 4 for PALISADE BIO, INC. (PALI) on 10 Jul 2026.

Key facts

This page summarizes Robert Baltera Jr.'s Form 4 filing for PALISADE BIO, INC. (PALI).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 10 Jul 2026, 18:14.

Change

Previous filing in this sequence was filed on 08 Jul 2026.
Current net transaction value: +$88,698.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001536555 Primary reporting owner

Baltera Robert Jr.

Relationship: Director
Address: C/O PALISADE BIO, INC., 4600 SOUTH SYRACUSE STREET, SUITE 900, DENVER
Signature: /s/ Ryker Willie, Attorney-in-Fact for Robert Baltera Jr.
Signature date: 10 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PALI transaction

Common Stock

Purchase

Transaction value: $39,798
Shares: +20,000
Change %: +4.8%
Price: $1.99
Shares after: 436,904
Date: 08 Jul 2026
Ownership: Direct
Footnotes: F1

PALI transaction

Common Stock

Purchase

Transaction value: $48,900
Shares: +25,000
Change %: +5.7%
Price: $1.96
Shares after: 461,904
Date: 09 Jul 2026
Ownership: Direct
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The price reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.98 to $2.00. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Footnote F2

The price reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.9298 to $1.98. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.